[小分子干凝的多尺度结构增强了Borneolum Syntheticum的稳定性和生物利用性]
Kai-Xuan Zhang1, Ya-Jun Shi1, Yu-Jie Liang1
1Key Laboratory of Basic and New Drug Research of Traditional Chinese Medicine of Shaanxi Province, School of Pharmacy, Shaanxi University of Chinese Medicine Xianyang 712046, China.
概括
研究人员开发了一种新的干凝系统,使用小分子凝器来稳定化学不稳定的Borneolum Syntheticum成分. 这种方法显著改善了封装,装载能力和体内释放特征,提高了中国传统医学的质量.
科学领域:
- 制药科学 制药科学
- 材料科学 材料科学 材料科学
- 传统中国医学 (TCM) 是一种
背景情况:
- 玻利合成物 (borneol和isoborneol) 的化学不稳定性限制了它的质量.
- 开发稳定的TCM配方对于治疗疗效至关重要.
研究的目的:
- 设计和合成用于稳定Borneolum Syntheticum的小分子凝器.
- 创建一个干凝自组装系统,以提高质量和稳定性.
主要方法:
- 基于胆固醇的小分子凝剂被合成和选.
- 构建了一个Borneolum Syntheticum-gelator干凝系统.
- 进行了物理化学表征 (IR,SEM,XRD,DSC) 和稳定性评估.
- 药物动力学研究评估了体内释放特征.
主要成果:
- 在1:1和3:1的比例下形成的最佳干凝具有高封装 (>98%) 和装载能力.
- 凝涉及结,形成纤维状网络,增强稳定性.
- XRD和DSC证实了晶体结构的掩盖和协同稳定.
- 3:1配方显示了延长的保留时间和稳定的体内释放.
结论:
- 一种新的干凝自组装系统有效地稳定不稳定的Borneolum Syntheticum组件.
- 这种方法提高了药物加载,封装效率和体内药物动力学概况.
- 这些发现为提高可降解TCM成分的质量提供了一个有希望的策略.
相关概念视频
01:05Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
193
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
193
01:21Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
660
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
660
01:27Bioavailability Enhancement: Drug Permeability Enhancement
183
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
183
01:20Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
493
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
493
01:23Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K
01:16Bioavailability Enhancement: Drug Solubility Enhancement
212
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
212